ES2344356T3 - Composicion farmaceutica que comprende drospirenona y etinilestradiol. - Google Patents
Composicion farmaceutica que comprende drospirenona y etinilestradiol. Download PDFInfo
- Publication number
- ES2344356T3 ES2344356T3 ES05777862T ES05777862T ES2344356T3 ES 2344356 T3 ES2344356 T3 ES 2344356T3 ES 05777862 T ES05777862 T ES 05777862T ES 05777862 T ES05777862 T ES 05777862T ES 2344356 T3 ES2344356 T3 ES 2344356T3
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical composition
- ethylestradiol
- composition including
- drospirenone
- including drospirenone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una composición farmacéutica que comprende drospirenona y etinilestradiol en forma amorfa, adsorbidos sobre un soporte sólido terapéuticamente inerte, en combinación con excipientes farmacéuticamente aceptables, caracterizada porque la composición comprende cantidades medibles del disolvente volátil cloruro de metileno.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04103837A EP1625849A1 (en) | 2004-08-09 | 2004-08-09 | Pharmaceutical composition comprising drospirenone and ethynylestradiol |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2344356T3 true ES2344356T3 (es) | 2010-08-25 |
Family
ID=34929434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES05777862T Active ES2344356T3 (es) | 2004-08-09 | 2005-08-02 | Composicion farmaceutica que comprende drospirenona y etinilestradiol. |
Country Status (20)
Country | Link |
---|---|
US (1) | US20090227546A1 (es) |
EP (2) | EP1625849A1 (es) |
JP (1) | JP2008509195A (es) |
KR (1) | KR20070045247A (es) |
CN (1) | CN101022811B (es) |
AR (1) | AR045576A1 (es) |
AT (1) | ATE464053T1 (es) |
AU (1) | AU2005271206B2 (es) |
BR (1) | BRPI0513938B8 (es) |
CA (1) | CA2574997A1 (es) |
DE (1) | DE602005020694D1 (es) |
ES (1) | ES2344356T3 (es) |
HK (1) | HK1109579A1 (es) |
IL (1) | IL180899A0 (es) |
MA (1) | MA28844B1 (es) |
NO (1) | NO20071297L (es) |
RU (1) | RU2007108666A (es) |
UA (1) | UA87513C2 (es) |
WO (1) | WO2006015956A1 (es) |
ZA (1) | ZA200702038B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009006823A (es) * | 2006-12-20 | 2009-07-03 | Duramed Pharmaceuticals Inc | Formas de dosificacion solidas de desintegracion oral que comprenden progestina y metodos para hacer y usar las mismas. |
HUP0700826A3 (en) * | 2007-12-20 | 2010-03-29 | Richter Gedeon Nyrt | Coated tablet containing drospirenone and process for producing the same |
DE102008037025C5 (de) | 2008-08-08 | 2016-07-07 | Jesalis Pharma Gmbh | Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform |
BRPI1016132B8 (pt) * | 2009-04-01 | 2021-05-25 | Bial Portela & Ca Sa | composição, formulação farmacêutica, processo de obtenção de uma formulação farmacêutica estável |
KR20120027197A (ko) | 2009-04-01 | 2012-03-21 | 바이알 - 포르텔라 앤드 씨에이 에스에이 | 니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법 |
AR081670A1 (es) | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
US10849857B2 (en) | 2010-07-28 | 2020-12-01 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
US11351122B1 (en) | 2010-07-28 | 2022-06-07 | Laboratorios Leon Farma Sa | Synthetic progestogens and pharmaceutical compositions comprising the same |
US9603860B2 (en) * | 2010-07-28 | 2017-03-28 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
CN102274235B (zh) * | 2011-06-27 | 2013-03-13 | 潍坊中狮制药有限公司 | 一种新的避孕药物组合及制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
FR2722984B1 (fr) * | 1994-07-26 | 1996-10-18 | Effik Lab | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
US6027747A (en) * | 1997-11-11 | 2000-02-22 | Terracol; Didier | Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions |
CA2382426C (en) * | 1999-08-31 | 2006-02-28 | Schering Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
JP4354667B2 (ja) * | 1999-08-31 | 2009-10-28 | バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト | 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ |
AU2742102A (en) * | 2000-12-14 | 2002-06-24 | Ortho Mcneil Pharm Inc | Steroid hormone products and methods for preparing them |
EP1216712A1 (en) * | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Cyclodextrin-drospirenone inclusion complexes |
-
2004
- 2004-08-09 EP EP04103837A patent/EP1625849A1/en not_active Withdrawn
- 2004-09-03 AR ARP040103168A patent/AR045576A1/es not_active Application Discontinuation
-
2005
- 2005-08-02 CA CA002574997A patent/CA2574997A1/en not_active Abandoned
- 2005-08-02 JP JP2007525283A patent/JP2008509195A/ja not_active Withdrawn
- 2005-08-02 ZA ZA200702038A patent/ZA200702038B/xx unknown
- 2005-08-02 ES ES05777862T patent/ES2344356T3/es active Active
- 2005-08-02 US US11/573,499 patent/US20090227546A1/en not_active Abandoned
- 2005-08-02 RU RU2007108666/15A patent/RU2007108666A/ru not_active Application Discontinuation
- 2005-08-02 WO PCT/EP2005/053759 patent/WO2006015956A1/en active Application Filing
- 2005-08-02 CN CN2005800271055A patent/CN101022811B/zh not_active Expired - Fee Related
- 2005-08-02 AU AU2005271206A patent/AU2005271206B2/en not_active Ceased
- 2005-08-02 BR BRPI0513938A patent/BRPI0513938B8/pt active IP Right Grant
- 2005-08-02 UA UAA200702482A patent/UA87513C2/ru unknown
- 2005-08-02 KR KR1020077003265A patent/KR20070045247A/ko not_active Application Discontinuation
- 2005-08-02 AT AT05777862T patent/ATE464053T1/de not_active IP Right Cessation
- 2005-08-02 EP EP05777862A patent/EP1848441B1/en not_active Revoked
- 2005-08-02 DE DE602005020694T patent/DE602005020694D1/de active Active
-
2007
- 2007-01-23 IL IL180899A patent/IL180899A0/en unknown
- 2007-03-02 MA MA29728A patent/MA28844B1/fr unknown
- 2007-03-09 NO NO20071297A patent/NO20071297L/no not_active Application Discontinuation
-
2008
- 2008-01-11 HK HK08100370.2A patent/HK1109579A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2574997A1 (en) | 2006-02-16 |
RU2007108666A (ru) | 2008-09-20 |
WO2006015956A1 (en) | 2006-02-16 |
BRPI0513938B1 (pt) | 2018-09-25 |
BRPI0513938A (pt) | 2008-05-20 |
AR045576A1 (es) | 2005-11-02 |
ATE464053T1 (de) | 2010-04-15 |
EP1848441B1 (en) | 2010-04-14 |
IL180899A0 (en) | 2007-07-04 |
BRPI0513938B8 (pt) | 2021-05-25 |
HK1109579A1 (en) | 2008-06-13 |
ZA200702038B (en) | 2008-08-27 |
US20090227546A1 (en) | 2009-09-10 |
AU2005271206B2 (en) | 2009-11-26 |
DE602005020694D1 (de) | 2010-05-27 |
CN101022811B (zh) | 2010-09-15 |
EP1625849A1 (en) | 2006-02-15 |
EP1848441A1 (en) | 2007-10-31 |
NO20071297L (no) | 2007-05-02 |
AU2005271206A1 (en) | 2006-02-16 |
MA28844B1 (fr) | 2007-09-03 |
UA87513C2 (ru) | 2009-07-27 |
KR20070045247A (ko) | 2007-05-02 |
CN101022811A (zh) | 2007-08-22 |
JP2008509195A (ja) | 2008-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2344356T3 (es) | Composicion farmaceutica que comprende drospirenona y etinilestradiol. | |
ATE540680T1 (de) | Pharmazeutische aripiprazol-zusammensetzungen | |
WO2007070632A3 (en) | Abuse resistant transmucosal drug delivery device | |
CL2012001080A1 (es) | Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida. | |
WO2008146178A3 (en) | A novel tablet dosage form | |
CL2011000101A1 (es) | Compuestos derivados de piridazina sustituida; inhibidores de la señalizacion hedgehog y smo; composicion farmaceutica; y uso para el tratamiento de trastornos o sindromes asociados con enfermedades hiperproliferativas. | |
RS52651B (en) | PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENS AND / OR ESTROGENS AND 5-METHYL- (6S) -TETRAHYDROPHOLATE | |
EP1789075A4 (en) | ABSORPTION ENHANCER FOR DRUG ADMINISTRATION | |
WO2006130628A3 (en) | Combination of hcv protease inhibitors with a surfactant | |
MX2013004137A (es) | Composicion farmaceutica. | |
MX2007007613A (es) | Formulaciones farmaceuticas. | |
WO2009063222A3 (en) | Solid compositions | |
WO2006023644A3 (en) | Transdermal drug delivery device with translucent protective film | |
IL188744A0 (en) | High drug load formulations and dosage forms | |
WO2006041878A3 (en) | Primary examiner | |
CY1114933T1 (el) | Στερεες φαρμακευτικες συνθεσεις σταθερης δοσης περιεχουσες ιρβεσαρτανη και αμλοδιπινη, η παρασκευη τους και η θεραπευτικη εφαρμογη τους | |
WO2010052466A8 (en) | Pharmaceutical aerosol composition | |
MX2009002356A (es) | Composiciones farmaceuticas que comprenden clopidogrel. | |
SM200500011A (it) | Una composizione farmaceutica antimicobatterica | |
CL2008000965A1 (es) | Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor. | |
NO20026244D0 (no) | Neurobeskyttende 7-beta-hydroksysteroider | |
WO2007054904A3 (en) | Macrolides as anti-inflammatory agents | |
WO2005110358A3 (de) | Filmförmiges, oral zu verabreichendes arzneimittel, enthaltend estriol | |
MX2019001771A (es) | Composición farmacéutica sólida que comprende el sofosbuvir amorfo. | |
WO2007010501A3 (en) | A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor |